<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33770234</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum.</ArticleTitle><Pagination><StartPage>3766</StartPage><EndPage>3776</EndPage><MedlinePgn>3766-3776</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10521-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">5-10% of amyotrophic lateral sclerosis (ALS) patients presented a positive family history (fALS). More than 30 genes have been identified in association with ALS/frontotemporal dementia (FTD) spectrum, with four major genes accounting for 60-70% of fALS. In this paper, we aimed to assess the contribution to the pathogenesis of major and rare ALS/FTD genes in ALS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed ALS and ALS/FTD associated genes by direct sequencing or next-generation sequencing multigene panels in ALS patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Genetic abnormalities in ALS major genes included repeated expansions of hexanucleotide in C9orf72 gene (7.3%), mutations in SOD1 (4.9%), FUS (2.1%), and TARDBP (2.4%), whereas variants in rare ALS/FTD genes affected 15.5% of subjects overall, most frequently involving SQSTM1 (3.4%), and CHMP2B (1.9%). We found clustering of variants in ALS major genes in patients with a family history for "pure" ALS, while ALS/FTD related genes mainly occurred in patients with a family history for other neurodegenerative diseases (dementia and/or parkinsonism).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data support the presence of two different genetic components underlying ALS pathogenesis, related to the presence of a family history for ALS or other neurodegenerative diseases. Thus, family history may help in optimizing the genetic screening protocol to be applied.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bartoletti-Stella</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Vacchiano</LastName><ForeName>Veria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Pasqua</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; Di Bologna, 40123, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mengozzi</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Biase</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacy and Biotechnology, Molecular Diagnostic Unit, University of Bologna, viale Ercolani 4/2, 40138, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartolomei</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avoni</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; Di Bologna, 40123, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; Di Bologna, 40123, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parchi</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Experimental Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40138, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donadio</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero Universitaria Citta Della Salute E Della Scienza Di Torino, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pession</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy and Biotechnology, Molecular Diagnostic Unit, University of Bologna, viale Ercolani 4/2, 40138, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oppi</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liguori</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; Di Bologna, 40123, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Capellari</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bellaria Hospital, 40139, Bologna, Italy. sabina.capellari@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Scienze Biomediche e Neuromotorie (DIBINEM), Universit&#xe0; Di Bologna, 40123, Bologna, Italy. sabina.capellari@unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>BoReALS</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Frontotemporal degeneration</Keyword><Keyword MajorTopicYN="N">Genetic heterogeneity</Keyword><Keyword MajorTopicYN="N">Mutation screening</Keyword><Keyword MajorTopicYN="N">Next generation sequencing</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>17</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33770234</ArticleId><ArticleId IdType="pmc">PMC8463338</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10521-w</ArticleId><ArticleId IdType="pii">10.1007/s00415-021-10521-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3&#x2013;4):153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Ciura S, Rouleau GA, Kabashi E. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) Trends Genet. 2015;31:263&#x2013;273. doi: 10.1016/j.tig.2015.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2015.03.005</ArticleId><ArticleId IdType="pubmed">25869998</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahheydari H, Ragagnin A, Walker AK, et al. Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum. Front Mol Neurosci. 2017;10:119. doi: 10.3389/fnmol.2017.00119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00119</ArticleId><ArticleId IdType="pmc">PMC5423993</ArticleId><ArticleId IdType="pubmed">28539871</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C. Non-familial ALS: a tangled web. Nature. 2017;550(7676):S109&#x2013;S111. doi: 10.1038/550S109a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/550S109a</ArticleId><ArticleId IdType="pubmed">29045373</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller MF, Ferrucci L, Singleton AB, et al. Genome-wide analysis of the heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2014;71(9):1123&#x2013;1134. doi: 10.1001/jamaneurol.2014.1184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1184</ArticleId><ArticleId IdType="pmc">PMC4566960</ArticleId><ArticleId IdType="pubmed">25023141</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Fang F, Hanby MF, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81(12):1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Couratier P, Blasco H, et al. Genetics of amyotrophic lateral sclerosis. Rev Neurol (Paris) 2017;173(5):254&#x2013;262. doi: 10.1016/j.neurol.2017.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.03.030</ArticleId><ArticleId IdType="pubmed">28449881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamp M, Origone P, Geroldi A, et al. Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients. Neurobiol Aging. 2018;66:179.e5&#x2013;179.e16. doi: 10.1016/j.neurobiolaging.2018.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.01.013</ArticleId><ArticleId IdType="pubmed">29525178</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V, Magri S, Bella ED, et al. Sorting rare ALS genetic variants by targeted re-sequencing panel in Italian patients: OPTN, VCP, and SQSTM1 variants account for 3% of rare genetic forms. J Clin Med. 2020;9(2):412. doi: 10.3390/jcm9020412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020412</ArticleId><ArticleId IdType="pmc">PMC7073901</ArticleId><ArticleId IdType="pubmed">32028661</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Ando Y. Genotype&#x2013;phenotype relationship in hereditary amyotrophic lateral sclerosis. Transl Neurodegener. 2015;4:13. doi: 10.1186/s40035-015-0036-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-015-0036-y</ArticleId><ArticleId IdType="pmc">PMC4513711</ArticleId><ArticleId IdType="pubmed">26213621</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoccaro MP, Bartoletti-Stella A, Piras S, et al. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature. J Neurol. 2017;264(7):1426&#x2013;1433. doi: 10.1007/s00415-017-8540-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8540-x</ArticleId><ArticleId IdType="pubmed">28620717</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangi G, Traynor BJ. Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges. Brain Res. 2015;1607:75&#x2013;93. doi: 10.1016/j.brainres.2014.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.10.009</ArticleId><ArticleId IdType="pmc">PMC5916786</ArticleId><ArticleId IdType="pubmed">25316630</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10(11):661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology. 2020;94(8):e802&#x2013;e810. doi: 10.1212/WNL.0000000000008869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621&#x2013;1626. doi: 10.1212/WNL.55.11.1621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.55.11.1621</ArticleId><ArticleId IdType="pubmed">11113214</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallassi R, Lenzi P, Stracciari A, et al. Neuropsychological assessment of mental deterioration: purpose of a brief battery and a probabilistic definition of &#x201c;normality&#x201d; and &#x201c;non-normality&#x201d;. Acta Psychiatr Scand. 1986;74:62&#x2013;67. doi: 10.1111/j.1600-0447.1986.tb06228.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1986.tb06228.x</ArticleId><ArticleId IdType="pubmed">3766185</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial amyotrophic lateral sclerosis. NeurolClin. 2015;33(4):807&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Visani M, de Biase D, Bartolomei I, et al. A novel T137A SOD1 mutation in an Italian family with two subjects affected by amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(5):385&#x2013;388. doi: 10.3109/17482968.2011.582648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.582648</ArticleId><ArticleId IdType="pubmed">21574856</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti-Stella A, Baiardi S, Stanzani-Maserati M, et al. Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing. Neurobiol Aging. 2018;66:180.e23&#x2013;180.e31. doi: 10.1016/j.neurobiolaging.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.02.006</ArticleId><ArticleId IdType="pubmed">29525180</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434&#x2013;443. doi: 10.1038/s41586-020-2308-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Barnwell J, Al-Chalabi A, Eisen A. Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain. 2012;135(Pt 9):2883&#x2013;2891. doi: 10.1093/brain/aws144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws144</ArticleId><ArticleId IdType="pubmed">22661746</ArticleId></ArticleIdList></Reference><Reference><Citation>Espay AJ, Litvan I. Extrapyramidal syndrome and frontotemporal dementia: the clinical overlap. J Mol Neurosci. 2011;45(3):343&#x2013;349. doi: 10.1007/s12031-011-9632-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9632-1</ArticleId><ArticleId IdType="pmc">PMC3324113</ArticleId><ArticleId IdType="pubmed">21892619</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A, Al Khleifat A, Jones AR, et al. C9orf72 intermediate expansions of 24&#x2013;30 repeats are associated with ALS. Acta Neuropathol Commun. 2019;7(1):115. doi: 10.1186/s40478-019-0724-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0724-4</ArticleId><ArticleId IdType="pmc">PMC6637621</ArticleId><ArticleId IdType="pubmed">31315673</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellera C, Castellotti B, Riggio MC, et al. Superoxide dismutase gene mutations in Italian patients with familial and sporadic amyotrophic lateral sclerosis: identification of three novel missense mutations. Neuromuscul Disord. 2001;11(4):404&#x2013;410. doi: 10.1016/S0960-8966(00)00215-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(00)00215-7</ArticleId><ArticleId IdType="pubmed">11369193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J, Corbera-Bellalta M, Nogales G, et al. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1? J Neurol Sci. 2006;247(1):21&#x2013;28. doi: 10.1016/j.jns.2006.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.03.006</ArticleId><ArticleId IdType="pubmed">16674979</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini F, Battistini S, Mancuso M, et al. D90A-SOD1 mutation in ALS: the first report of heterozygous Italian patients and unusual findings. Amyotroph Lateral Scler. 2010;11(1&#x2013;2):216&#x2013;219. doi: 10.3109/17482960902721642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902721642</ArticleId><ArticleId IdType="pubmed">20184519</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosler BA, Nicholson GA, Sapp PC, et al. Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromuscul Disord. 1996;6(5):361&#x2013;366. doi: 10.1016/0960-8966(96)00353-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0960-8966(96)00353-7</ArticleId><ArticleId IdType="pubmed">8938700</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong SQ, Liu XN, Yang WB, Zhou YN, Wang JC, Chen XJ (2020) An exon 5 mutation (c.425G&gt;C, p.Gly141Ala) in the SOD1 gene in a Chinese family associated with incomplete penetrance [published online ahead of print, 2020 Mar 15]. Amyotroph Lateral Scler Frontotemporal Degener1&#x2013;4</Citation><ArticleIdList><ArticleId IdType="pubmed">32174179</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Conte A, Zollino M, et al. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology. 2012;79(1):66&#x2013;72. doi: 10.1212/WNL.0b013e31825dceca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31825dceca</ArticleId><ArticleId IdType="pubmed">22722621</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, Rolfs A, Meyer T. Heterozygous S44L missense change of the spastin gene in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9(4):251&#x2013;253. doi: 10.1080/17482960801900172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801900172</ArticleId><ArticleId IdType="pubmed">18608088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Kapogiannis D, Huey ED, Momeni P. FTD and ALS: a tale of two diseases. Curr Alzheimer Res. 2011;8(3):273&#x2013;294. doi: 10.2174/156720511795563700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511795563700</ArticleId><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappella M, Ciotti C, Cohen-Tannoudji M, Biferi MG. Gene therapy for ALS-A perspective. Int J Mol Sci. 2019;20(18):4388. doi: 10.3390/ijms20184388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184388</ArticleId><ArticleId IdType="pmc">PMC6771059</ArticleId><ArticleId IdType="pubmed">31500113</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson SB, Downie JM, Tsetsou S, et al. The evolving genetic risk for sporadic ALS. Neurology. 2017;89(3):226&#x2013;233. doi: 10.1212/WNL.0000000000004109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004109</ArticleId><ArticleId IdType="pmc">PMC5513819</ArticleId><ArticleId IdType="pubmed">28642336</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajda A, McLaughlin RL, Heverin M, et al. Genetic testing in ALS: a survey of current practices. Neurology. 2017;88(10):991&#x2013;999. doi: 10.1212/WNL.0000000000003686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003686</ArticleId><ArticleId IdType="pmc">PMC5333513</ArticleId><ArticleId IdType="pubmed">28159885</ArticleId></ArticleIdList></Reference><Reference><Citation>De Roeck A, Van Broeckhoven C, Sleegers K. The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics. Acta Neuropathol. 2019;138(2):201&#x2013;220. doi: 10.1007/s00401-019-01994-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01994-1</ArticleId><ArticleId IdType="pmc">PMC6660495</ArticleId><ArticleId IdType="pubmed">30903345</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34(6):404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17(1):17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone B, Conforti FL (2020) Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: how common are common mutations in ALS genes? [published online ahead of print, 2020 Jun 16]. Expert Rev Mol Diagn 1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">32497448</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81(4):385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P (2020) Amyotrophic lateral sclerosis: a clinical review [published online ahead of print, 2020 Jun 11]. Eur J Neurol. 10.1111/ene.14393</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Ke YD, Ittner LM, Halliday GM. ALS/FTLD: experimental models and reality. Acta Neuropathol. 2017;133(2):177&#x2013;196. doi: 10.1007/s00401-016-1666-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1666-6</ArticleId><ArticleId IdType="pubmed">28058507</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Wen N, Fan CC, et al. Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurol. 2018;75(7):860&#x2013;875. doi: 10.1001/jamaneurol.2018.0372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0372</ArticleId><ArticleId IdType="pmc">PMC6043387</ArticleId><ArticleId IdType="pubmed">29630712</ArticleId></ArticleIdList></Reference><Reference><Citation>Roggenbuck J, Quick A, Kolb SJ. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians. Genet Med. 2017;19(3):267&#x2013;274. doi: 10.1038/gim.2016.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2016.107</ArticleId><ArticleId IdType="pubmed">27537704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88(7):540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong RA. On the 'classification' of neurodegenerative disorders: discrete entities, overlap or continuum? Folia Neuropathol. 2012;50(3):201&#x2013;208. doi: 10.5114/fn.2012.30521.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2012.30521</ArticleId><ArticleId IdType="pubmed">23023335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) Biochim Biophys Acta. 2015;1852(4):679&#x2013;684. doi: 10.1016/j.bbadis.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz R, M&#xfc;ller K, Brenner D, et al. SQSTM1/p62 variants in 486 patients with familial ALS from Germany and Sweden. Neurobiol Aging. 2020;87:139.e9&#x2013;139.e15. doi: 10.1016/j.neurobiolaging.2019.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.10.018</ArticleId><ArticleId IdType="pubmed">31859009</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoccaro MP, Bartoletti-Stella A, Piras S, et al. The first historically reported Italian family with FTD/ALS teaches a lesson on C9orf72 RE: clinical heterogeneity and oligogenic inheritance. J Alzheimers Dis. 2018;62(2):687&#x2013;697. doi: 10.3233/JAD-170913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170913</ArticleId><ArticleId IdType="pubmed">29480190</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amore A, Tessa A, Casali C, et al. Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study. Front Neurol. 2018;9:981. doi: 10.3389/fneur.2018.00981.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00981</ArticleId><ArticleId IdType="pmc">PMC6289125</ArticleId><ArticleId IdType="pubmed">30564185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>